Supernus Pharmaceuticals vs Tortugas Neuroscience
Supernus Pharmaceuticals vs Tortugas Neuroscience, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Supernus Pharmaceuticals is on 60/100 and Tortugas Neuroscience on 51/100.
Where each one leads
Supernus Pharmaceuticals
- our overall score: 60/100 against 51/100
- domain rating: 67/100 against 10/100
- headcount: 809 against 2
Tortugas Neuroscience
- funding raised: $164M against $17.5M
At a glance
| Measure | Supernus Pharmaceuticals | Tortugas Neuroscience |
|---|---|---|
| What it is | Biopharmaceutical company developing and commercializing CNS disease treatments. | Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2005 | 2024 |
| Headquarters | Rockville, United States | Framingham, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Supernus Pharmaceuticals | Tortugas Neuroscience |
|---|---|---|
| Employees | 809 | 2 |
| Total funding | $17.5M | $164M |
| Latest round | Series A | Series A |
| LinkedIn followers | Not published | 113 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Supernus Pharmaceuticals | Tortugas Neuroscience |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 51/100 |
| Traction | 56/100 | 45/100 |
| Team | 30/100 | 60/100 |
| Search visibility | 15/100 | 30/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Supernus Pharmaceuticals | Tortugas Neuroscience |
|---|---|---|
| Hosting | AWS | AWS |
| Frameworks | Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Supernus Pharmaceuticals vs Tortugas Neuroscience: common questions
Which is better, Supernus Pharmaceuticals or Tortugas Neuroscience?
On our 0-100 score Supernus Pharmaceuticals rates higher (60/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Supernus Pharmaceuticals and Tortugas Neuroscience compare on the numbers?
Supernus Pharmaceuticals leads on our overall score (60/100 against 51/100), domain rating (67/100 against 10/100), headcount (809 against 2). Tortugas Neuroscience leads on funding raised ($164M against $17.5M).
Read the full Supernus Pharmaceuticals review and pricing or the Tortugas Neuroscience review and pricing. You can also browse other Supernus Pharmaceuticals alternatives we track.